文献速递关节外科

LCS股骨假体表面改性失效机制:Duofix与Porocoat取回研究

The effect of implant modification: the low contact stress experience.
PubMed 文献 · Bone Joint J · 2019-01-01

该研究对104例无骨水泥LCS股骨假体取回物进行分组分析,比较Duofix(羟基磷灰石涂层,已被厂商自愿召回)与Porocoat的失效机制。Duofix组松动几率降低,但金属沉着、组织染色及嵌入金属碎屑增加,组织长入减少,附着微珠微硬度降低。结论认为Duofix与Porocoat并不等效,尽管其通过FDA 510(k)等效审批。

要点

  • Duofix组相对Porocoat组松动几率降低,但金属沉着和组织染色增加(p=0.028)。
  • Duofix组嵌入金属碎屑增加(p<0.001),组织长入减少(p<0.001)。
  • 附着微珠微硬度降低,提示不良热加工,导致微珠脱落、颗粒碎屑和金属沉着。

核心结论

  • LCS股骨假体羟基磷灰石涂层产生意外结果并导致召回,根因可能为残留氧化铝砂粒与微珠微硬度降低共同导致颗粒碎屑、金属沉着和早期翻修。
  • Duofix LCS股骨假体与Porocoat版本并不等效,尽管其通过FDA 510(k)等效审批流程。
  • 现有器械改性引入的监管需要改进,Duofix LCS在引入时应被视为等效性尚未证实的新器械。

研究设计与样本

  • 对无骨水泥LCS取回物进行取回研究,分为Duofix、Porocoat和混合三组。
  • 共分析104例植入物,进行人口统计学、聚乙烯磨损、组织长入和冶金学分析。

主要发现

  • Duofix组相对Porocoat组松动几率降低,金属沉着和组织染色增加(p=0.028)。
  • Duofix组嵌入金属碎屑增加(p<0.001)。
  • Duofix表面与组织长入减少相关(p<0.001)。
  • 附着微珠微硬度降低,提示不良热加工,导致微珠脱落、颗粒碎屑和金属沉着。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim of this study was to conduct the largest low contact stress (LCS) retrieval study to elucidate the failure mechanisms of the Porocoat and Duofix femoral component. The latter design was voluntarily recalled by the manufacturer. MATERIALS AND METHODS: Uncemented LCS explants were divided into three groups: Duofix, Porocoat, and mixed. Demographics, polyethylene wear, tissue ingrowth, and metallurgical analyses were performed. RESULTS: In 104 implants, a decrease in the odds of loosening and an increase in metallosis and tissue staining in the Duofix group relative to Porocoat group was detected (p = 0.028). There was an increased presence of embedded metallic debris in the Duofix group (p < 0.001). Decreased tissue ingrowth was associated with the Duofix surface (p < 0.001). The attached beads had reduced microhardness, indicative of adverse thermal processing, which resulted in bead shedding, particulate debris, and metallosis. CONCLUSION: Hydroxyapatite coating of the LCS femoral component produced unexpected results and led to its recall. The root cause was likely a combination of retained alumina grit and a reduction in bead microhardness (mechanical strength) resulting in increased particle debris, metallosis, and early revision. The Duofix LCS femoral component was not equivalent to the Porocoat version despite its approval through the Food and Drug Administration (FDA) 510(k) equivalance approval process. Regulation of the introduction of modified existing devices needs to be improved and the Duofix LCS should have been considered to be a new device for which equivalence had not been demonstrated at the point of introduction. Cite this article: Bone Joint J 2019;101-B:1248-1255.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Pineda A, Pabbruwe MB, Kop AM, et al. The effect of implant modification: the low contact stress experience. Bone Joint J. 2019. PMID: 31564141. doi:10.1302/0301-620X.101B10.BJJ-2019-0135.R2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。